SCHEMBL166677

SCHEMBL166677

CC/C=C\CCOC(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.41
NR1I2 O75469 2/20 0.41
PTGS2 P35354 2/20 0.41
PGR P06401 1/20 0.41
PDE4D Q08499 1/20 0.41
ALDH1A1 P00352 9/20 0.39
MAPT P10636 4/20 0.39
CYP19A1 P11511 4/20 0.39
PPARG P37231 3/20 0.39
OXER1 Q8TDS5 3/20 0.39
RXRA P19793 2/20 0.39
FFAR1 O14842 2/20 0.39
CYP3A4 P08684 2/20 0.39
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 1/20 0.39
LPAR2 Q9HBW0 2/20 0.38
LPAR3 Q9UBY5 2/20 0.38
LPAR1 Q92633 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1357663 1.00 ADORA3 (0.41) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL166678 1.00 ADORA3 (0.41) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL6648981 0.91 ALOX15 (0.34) ALDH1A1ALOX15TSHRFAAHCNR1
SCHEMBL28231787 0.89 ADORA3 (0.44) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL6945278 0.89 ADORA3 (0.44) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL6945280 0.89 ADORA3 (0.44) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL30496767 0.88 TAS1R3 (0.39) FAAHCNR1
SCHEMBL9581338 0.82 FAAH (0.45) LPAR2LPAR3LPAR1FAAH
SCHEMBL6949763 0.82 PTGS1 (0.40) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL6949758 0.82 PTGS1 (0.40) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1042 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214303-B1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2026-05-06 EP claimed
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
EP-4704791-A1 ETHANOL-FREE FRAGRANCE MICROEMULSION Coty Inc. (US) 2026-03-11 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
US-12522786-B2 Organic compounds GIVAUDAN SA (CH) 2026-01-13 US claimed
US-20250302728-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD SYMRISE AG (DE) 2025-10-02 US claimed
WO-2025202258-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-10-02 WO claimed
US-12421475-B2 High performing, high impact bloom accord with a top, medium, and base note mixture INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-09-23 US claimed
EP-4526411-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD Symrise AG (DE) 2025-03-26 EP claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
WO-2008023142-A1 PERFUME COMPOSITIONS GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-02-28 WO claimed
WO-2008017820-A1 PERFUME COMPOSITIONS GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-02-14 WO claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
US-20050160538-A1 Fragance of 3-cis hexenol and ethanolamine to improve odor KAO CORPORATION (JP) 2005-07-28 US claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
US-6844302-B1 Encapsulated flavor and fragrance INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2005-01-18 US claimed
EP-0955035-B1 Method of preventing aged body odor SHISEIDO CO LTD (JP) 2004-09-29 EP claimed
US-20020058017-A1 Hair cosmetic compositions KAO CORPORATION (JP) 2002-05-16 US claimed
EP-1190696-A2 Hair cosmetic compositions and use thereof Kao Corporation (JP) 2002-03-27 EP claimed
EP-0955035-A1 Body odor preventing composition SHISEIDO COMPANY LIMITED (JP) 1999-11-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 ADORA3 4838/4885NR1I2 4294/4885PTGS2 3147/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 ADORA3 3383/4885NR1I2 476/4885PTGS2 916/4885
US-20020058017-A1 Hair cosmetic compositions FHIT, MITF, HNMT ADORA3 325/4885NR1I2 1018/4885PTGS2 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.